Phentermine, a psychotropic appetite suppressant, was found to have the highest number of reported adverse events among anti-obesity drugs prescribed in Korea.

Saxenda, an anti-obesity drug that was developed by changing the MOA of a diabetes drug, had the second-most reported number of side effects after phentermine.

On the 7th, the joint research team of the Kyung Hee University College of Pharmacy, Ajou University Hospital, and Ajou University College of Pharmacy announced that phentermine and Saxenda (liraglutide) were the most common causative anti-obesity medications after analyzing 13,766 adverse drug event cases spontaneously reported to the Korea Adverse Event Reporting System